BUZZ — India's Global Health rises after Investec initiates with "buy"

* Investec initiates coverage of Medanta hospital operator Global Health with "buy" rating and PT of 1,730 rupees * Co's shares up 3.1% at 1,467.90 rupees * Investec says Medanta brand's focus on tertiary and quaternary specialties, along with strong presence in India's National Capital Region (NCR), underpins an industry-leading payor mix * Brokerage says it expects overall EBITDAM set to improve by ~400 bps to ~25% by FY29, driven by Noida hospital breakeven in 2HFY27 and ramp-up in Lucknow, Patna, Ranchi, and Indore clusters * Brokerage notes that out of 3,440 planned bed additions, 2,950 greenfield beds will be commissioned post-FY29, which will not impact profitability * Forecasts revenue and EBITDA CAGR of 16% and 23%, respectively, over FY26—FY29E * Stock rated "buy" on average by 15 analysts; median PT is 1,586 rupees - data compiled * Stock up 23.7% YTD (Reporting by Payel Das in Bengaluru) ((Payel.das@thomsonreuters.com)